US 12,114,008

Application 17/765,391 · Granted Oct 8, 2024

Method and apparatus for inter-prediction of pictures with different resolutions

Estimated expiration

March 3, 2041

14y 105d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTKR2020013309: Resource not found (404)
Earliest effective filing
Sep 29, 2020
+ 20 years
Sep 29, 2040
PTA +155d
Mar 3, 2041
No TD
—
Final
Mar 3, 2041

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
March 30, 2022
Earliest effective filing
September 29, 2020
Issue date
October 8, 2024
PTA
+155 days
Base expiry (before PTA)
September 29, 2040

September 29, 2020 + 20 years = September 29, 2040 + 155 PTA days = March 3, 2041

  • National stage entry of application PCTKR2020013309, filed Sep 29, 2020

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/765,391 · US 12,114,008

PatentReply compiles the prosecution history behind US 12,114,008: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12114008

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.